Glucotrack GCTK
NASDAQ GCTK
$1.21 -0.20 (-14.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Glucotrack (GCTK) Change in Accured Expenses (2010)

Updated

Glucotrack (GCTK) reported Change in Accured Expenses of $27,695 for Q4 2010.

Analysis

Glucotrack (GCTK) Change in Accured Expenses (2010) Analysis & Trends

For FY2010, Glucotrack posted Change in Accured Expenses of $78,192.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn -
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn -
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn -249.00 Mn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 55.00 Mn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn -531.00 Mn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 298.00 Mn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 234.00 Mn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 123.70 Mn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn -
10 Glucotrack 404,066.20 -25.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 27,695.00
API Access

Glucotrack Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=GCTK&period=max&api_key=YOUR_API_KEY